Ticker > IPO > newlisted > Mankind Pharma Ltd.

IPO

Mankind Pharma Ltd.

The company is India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022. It is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

RHP
View
DRHP
View
Open Date

2023-04-25

Close Date

2023-04-27

IPO Details

Check out the issue details for Mankind Pharma Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1080

Price Band

₹ 1026 - 1080

Issue Size

4326.36 Cr.

Issue Type

Book Built

Open

2023-04-25

Close

2023-04-27

Listingprice

₹ 1300

ListingGain

20.37%

Listing Date

2023-05-09

CMP

₹ 1909

Current Return

76.76%

News

Mankind Pharma informs about analyst meet18 Nov, 3:51PM Mankind Pharma - Quaterly Results31 Oct, 5:26PM Mankind Pharma - Quaterly Results31 Oct, 5:26PM Mankind Pharma informs about receipt of request for reclassification of shareholding 28 Oct, 12:22PM Mankind Pharma - Quaterly Results2 Aug, 6:11PM Mankind Pharma - Quaterly Results2 Aug, 6:11PM Mankind Pharma informs about board meeting 18 Jul, 10:17AM Mankind Pharma informs about disclosure31 May, 3:58PM Mankind Pharma coming up with IPO to raise around Rs 4326 crore21 Apr, 12:57PM

Company Financials

You can get the following financial statements of Mankind Pharma Ltd. as of now.

Company Name

Mankind Pharma Ltd.

Exchange

NSE: MANKIND BSE: 543904

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Subscription Details

The details about the Mankind Pharma IPO is as:

  • The issue size of the IPO is 4326.36 Cr.
  • The price band for Mankind Pharma IPO is Rs 1026 to Rs 1080.
  • The shares of Mankind Pharma IPO will list on 9th May 2023.
  • The latest tentative GMP of Mankind Pharma IPO is Rs 97.
  • The shares of Mankind Pharma IPO is subscribed 15.32 Times as of 27th April 2023.

 

Mankind Pharma Ltd IPO Valuation

The approx valuation of Mankind Pharma Ltd IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 1080
Existing Shares (Qty) 40.05 Cr
EPS  Rs 35.78
PE Ratio 30.18x
Industry PE 40.16x

 

Mankind Pharma Ltd IPO Issue Size

Mankind Pharma Ltd IPO issue size is 4326.36 Cr.

Issue Amount
Fresh Issue 0 Cr
Offer For Sale 4326.36 Cr

 

Mankind Pharma Ltd IPO Market Lot

An Individual can apply for a minimum 1 lot of 13 shares and a maximum of 14 lots of 182 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 13 Rs 14,040
 Maximum 14 182 Rs 1,96,560

 

Mankind Pharma Ltd IPO Offer

The shares of Mankind Pharma IPO is subscribed 15.32 Times as of 27th April 2023. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 49.16 Times
Non-Institutional Minimum 15% 3.80 Times
Retail Individual Minimum 35% 0.92 Times
Total   15.32 Times

 

Mankind Pharma IPO Grey Market Premium

As on GMP (Tentative)
28 April 2023 Rs 30
1 May 2023 Rs 80
2 May 2023 Rs 90
3 May 2023 Rs 80
4 May 2023 Rs 80
5 May 2023 Rs 97

Mankind Pharma IPO GMP is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Allotment Details

Find below the dates for Mankind Pharma Ltd IPO:

Schedule Date
Basis of Allotment 3 May 2023
Refunds 4 May 2023
Credit to Demat Account 5 May 2023
IPO Listing Date 9 May 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 3829.06 4794.41 5523.18 7486.22 8127.15
Total Expenditure 3124.1 3550.47 4151.05 5647.73 6429.29
Operating Profit 704.96 1243.94 1372.13 1838.49 1697.86
Other Income 64.33 93.85 154.5 203.81 162.78
Interest 39.61 11.1 8.23 47.54 28.23
Depreciation 38.39 61.77 78.19 123.33 269.58
Exceptional Items 0 0 0 0 0
Profit Before Tax 691.3 1264.92 1440.21 1871.44 1562.84
Provision for Tax 177.26 306.7 355.83 482.01 314.58
Net Profit 514.04 958.23 1084.37 1389.42 1248.26
Adjusted EPS (Rs.) 1.28 2.39 2.71 3.47 3.12

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 40.06 40.06 40.06 40.06 40.06
Total Reserves 3024.76 3611.39 4694.21 6500.39 7743.85
Borrowings 0 0 0 0 0
Other N/C liabilities 60.6 42.84 54.11 126.98 168.12
Current liabilities 725.15 815.77 1078.91 2271.27 1419.09
Total Liabilities 3850.57 4510.06 5867.29 8938.7 9371.12
Assets
Net Block 767.52 939.25 981.95 2921.3 3136.89
Capital WIP 210.04 143.93 165.51 355.28 437.83
Intangible WIP 1.07 3.69 0.06 31.28 56.95
Investments 1394.24 1395.02 1500.86 1657.08 2040.76
Loans & Advances 92.8 77.6 115.59 146.3 148.86
Other N/C Assets 2.61 1.96 13.34 14.45 36.1
Current Assets 1382.29 1948.6 3089.98 3813.01 3513.72
Total Assets 3850.57 4510.06 5867.29 8938.7 9371.12
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023
Other Income 42.46 57.44 58.12
Profit Before Tax 355.43 526.39 611.96
Tax 74.45 117.11 139.08
Profit After Tax 280.99 409.28 472.89
Adjusted EPS (Rs) 7.01 10.22 11.8

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2023 76.5 0
Jun 2023 76.5 0
Mar 2023 76.5 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 691.3 1264.92 1440.21 1871.44 1562.84
Adjustment 32.07 137.23 96.74 -4.16 227
Changes in Assets & Liabilities 59.1 -168.42 -156.19 -585.61 294.21
Tax Paid -245.94 -274.12 -397.38 -460.22 -285.06
Operating Cash Flow 536.52 959.61 983.38 821.44 1798.99
Investing Cash Flow -305.58 -395.68 -1127.16 -1360.27 -1040.61
Financing Cash Flow -239.81 -558.91 88.87 578.63 -710.41
Net Cash Flow -8.87 5.02 -54.91 39.81 47.96
X